CoChat

Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer

Open access

The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.

Abstract

Primary triple negative breast cancers (TNBC) are prone to dissemination but sub-clonal relationships between tumors and resulting metastases are poorly understood. Here we use cellular barcoding of two treatment-naïve TNBC patient-derived xenografts (PDXs) to track the spatio-temporal fate of thousands of barcoded clones in primary tumors, and their metastases. Tumor resection had a major impact on reducing clonal diversity in secondary sites, indicating that most disseminated tumor cells lacked the capacity to ‘seed’, hence originated from ‘shedders’ that did not persist. The few clones that continued to grow after resection i.e. ‘seeders’, did not correlate in frequency with their parental clones in primary tumors. Cisplatin treatment of one BRCA1-mutated PDX model to non-palpable levels had a surprisingly minor impact on clonal diversity in the relapsed tumor yet purged 50% of distal clones. Therefore, clonal features of shedding, seeding and drug resistance are important factors to consider for the design of therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-08595-2

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Experimental overview, and spatio-temporal clonal heterogeneity in pseudo-primary tumors. a Cellular barcoding of PDXs transplanted into NSG mice and interrogated at different time points and under various conditions. Primary tumors and/or metastases were collected at early stage (T1; 46 days for PDX-110 and 41 days for PDX-322), tumors at ethical-endpoint (T2; 95 days for PDX-110, 58 days for PDX-322), late metastatic disease after tumor resection (T3; 71 days after tumor resection for PDX-110, 84 days for PDX-322), and tumor relapse after chemotherapy (T4; for PDX-110, 110 days for 1 cycle Cisplatin, 130 days for 2 cycles). Times of harvest are the mean. b Engraftment efficiencies of PDX-110 and PDX-322 assessed at T1 and T2 (Welch two-sided two sample t-test, ns: non-significant, p > 0.05). c Frequency distribution of clones at T1 and T2 pooled over several mice (PDX-110: 16 mice at T1 from two independent experiments, 17 mice at T2 from two independent experiments, PDX-322: 23 mice at T1 from four independent experiments, 19 mice at T2 from three independent experiments). Total numbers of barcodes used for this analysis are indicated next to the respective distributions. d Cumulative size distribution of barcoded clones in primary tumor for PDX-110 and PDX-322 (PDX-110: 16 mice at T1, 17 mice at T2, PDX-322: 23 mice at T1, 19 mice at T2)
Fig. 1 Experimental overview, and spatio-temporal clonal heterogeneity in pseudo-primary tumors. a Cellular barcoding of PDXs transplanted into NSG mice and interrogated at different time points and under various conditions. Primary tumors and/or metastases were collected at early stage (T1; 46 days for PDX-110 and 41 days for PDX-322), tumors at ethical-endpoint (T2; 95 days for PDX-110, 58 days for PDX-322), late metastatic disease after tumor resection (T3; 71 days after tumor resection for PDX-110, 84 days for PDX-322), and tumor relapse after chemotherapy (T4; for PDX-110, 110 days for 1 cycle Cisplatin, 130 days for 2 cycles). Times of harvest are the mean. b Engraftment efficiencies of PDX-110 and PDX-322 assessed at T1 and T2 (Welch two-sided two sample t-test, ns: non-significant, p > 0.05). c Frequency distribution of clones at T1 and T2 pooled over several mice (PDX-110: 16 mice at T1 from two independent experiments, 17 mice at T2 from two independent experiments, PDX-322: 23 mice at T1 from four independent experiments, 19 mice at T2 from three independent experiments). Total numbers of barcodes used for this analysis are indicated next to the respective distributions. d Cumulative size distribution of barcoded clones in primary tumor for PDX-110 and PDX-322 (PDX-110: 16 mice at T1, 17 mice at T2, PDX-322: 23 mice at T1, 19 mice at T2)CC BY · PubMed Central
Fig. 2 Clonal mosaicism in three dimensions. Example of tumor cut into a Eight equal pieces for PDX-110 and b 12 equal pieces for PDX-322. c, d Representative bubble plot of clonal relationships between tumor pieces shown in a and b, respectively. Each barcode is represented by a dot of a given color, the size of the dot correlates with the number of reads after sequencing. The color codes are not related between different mice. e, f Heatmap representation with hierarchical clustering of clonal relationships for the example shown in a and b, with barcodes in columns and tumor pieces in rows. g, h Force-directed graph-based spatial reconstruction of tumor using Hellinger distance between barcode distributions in pieces. i Contribution to tumor biomass as a function of the number of pieces a given clone is detected for a and b. Welch two-sided two sample t-test, *p < 0.05, ns = non significant. j Relationship of % biomass and dispersion (defined as the number of pieces a barcode is detected scaled by the total number of pieces per tumor) pooled over several mice (PDX-110: 17 mice, PDX-322, 19 mice). k Simulation and visualization of three-dimensional tumor growth, initiated with 200 barcoded PDX cells. Each dot is a cell, and colors indicate cells with different barcodes. l Bubble plot of a virtual tumor cut into eight equal pieces
Fig. 2 Clonal mosaicism in three dimensions. Example of tumor cut into a Eight equal pieces for PDX-110 and b 12 equal pieces for PDX-322. c, d Representative bubble plot of clonal relationships between tumor pieces shown in a and b, respectively. Each barcode is represented by a dot of a given color, the size of the dot correlates with the number of reads after sequencing. The color codes are not related between different mice. e, f Heatmap representation with hierarchical clustering of clonal relationships for the example shown in a and b, with barcodes in columns and tumor pieces in rows. g, h Force-directed graph-based spatial reconstruction of tumor using Hellinger distance between barcode distributions in pieces. i Contribution to tumor biomass as a function of the number of pieces a given clone is detected for a and b. Welch two-sided two sample t-test, *p < 0.05, ns = non significant. j Relationship of % biomass and dispersion (defined as the number of pieces a barcode is detected scaled by the total number of pieces per tumor) pooled over several mice (PDX-110: 17 mice, PDX-322, 19 mice). k Simulation and visualization of three-dimensional tumor growth, initiated with 200 barcoded PDX cells. Each dot is a cell, and colors indicate cells with different barcodes. l Bubble plot of a virtual tumor cut into eight equal piecesCC BY · PubMed Central
Fig. 3 Clonal relationships between primary tumor and distal sites. a Number of barcoded cells detected in tumor (approximation), blood, and lung at T2. Bars represent means ± SEM. *p < 0.05. ns = non-significant. Number of cells in tumor are estimated from tumor volume (see Methods). Number of cells in blood and lung correspond to GFP+ cells FACS-sorted from whole blood or lung. b Number of clones detected in tumor, blood, and lung at T2. Bars represent means ± SEM. Welch two-sided two sample t-test, *p < 0.05, ns = non-significant. c Percentage of the biomass of primary tumor represented in blood and lung at T2. Bars represent means ± SEM *p < 0.05. Welch two-sided two sample t-test, *p < 0.05, ns = non-significant. For b and c, filled dots represent data and empty triangles represent the results obtained by simulation. d Clonal overlap between tumor, blood, and lung. e Representative bubble plots of clonal relationships between primary tumors, CTCs, and lung DTCs. f Scatter plots of clonal frequencies of tumor versus blood, tumor versus lung, and lung versus blood. Dots on the axis are barcodes only found in one tissue, and dispersed for ease of visualization. Different shades of red and gray indicate different mice (n = 19 mice for PDX-110 from three independent experiments and n = 13 mice for PDX-322 from three independent experiments). Inset gives adjusted R2 and p-values using the F-test for linear regression on log-transformed frequencies of barcodes detected in both tissues. g Correlations in log-transformed clonal frequencies detected in two respective tissues. Each dot represents a mouse (n = 19 mice for PDX-110 from three independent experiments and n = 13 mice for PDX-322 from three independent experiments). Bars represent mean ± SEM. Welch two-sided two sample t-test, *p < 0.05, ns = non-significant. h Relationship of % biomass and dispersion for clones detected and not detected in lung (mean ± SEM)
Fig. 3 Clonal relationships between primary tumor and distal sites. a Number of barcoded cells detected in tumor (approximation), blood, and lung at T2. Bars represent means ± SEM. *p < 0.05. ns = non-significant. Number of cells in tumor are estimated from tumor volume (see Methods). Number of cells in blood and lung correspond to GFP+ cells FACS-sorted from whole blood or lung. b Number of clones detected in tumor, blood, and lung at T2. Bars represent means ± SEM. Welch two-sided two sample t-test, *p < 0.05, ns = non-significant. c Percentage of the biomass of primary tumor represented in blood and lung at T2. Bars represent means ± SEM *p < 0.05. Welch two-sided two sample t-test, *p < 0.05, ns = non-significant. For b and c, filled dots represent data and empty triangles represent the results obtained by simulation. d Clonal overlap between tumor, blood, and lung. e Representative bubble plots of clonal relationships between primary tumors, CTCs, and lung DTCs. f Scatter plots of clonal frequencies of tumor versus blood, tumor versus lung, and lung versus blood. Dots on the axis are barcodes only found in one tissue, and dispersed for ease of visualization. Different shades of red and gray indicate different mice (n = 19 mice for PDX-110 from three independent experiments and n = 13 mice for PDX-322 from three independent experiments). Inset gives adjusted R2 and p-values using the F-test for linear regression on log-transformed frequencies of barcodes detected in both tissues. g Correlations in log-transformed clonal frequencies detected in two respective tissues. Each dot represents a mouse (n = 19 mice for PDX-110 from three independent experiments and n = 13 mice for PDX-322 from three independent experiments). Bars represent mean ± SEM. Welch two-sided two sample t-test, *p < 0.05, ns = non-significant. h Relationship of % biomass and dispersion for clones detected and not detected in lung (mean ± SEM)CC BY · PubMed Central
Fig. 4 Characteristics of metastatic ‘seeder’ clones after tumor resection. Clonal relationships between resected primary tumor at T1 vs. metastatic lung disease at T3 in a PDX-110 and b PDX-322. Each color represents the clones from one mouse of a total of seven mice for PDX-110 from two independent experiments, n = 9 mice for PDX-322 from three independent experiments. Inset gives adjusted R2 and p-values using the F-test for linear regression on log-transformed frequencies of barcodes detected in both tissues. c Correlation of clonal relationship between indicated organs based on a and b between distal tissues at T3 compared to resected primary tumor at T1. Data represent 20 mice for PDX-110 from two independent experiments and 23 mice for PDX-322 from four independent experiments (mean ± SEM). d Change in the proportion of barcodes detected in lung prior to (T1) and after (T3) tumor resection in the indicated PDX (mean ± SEM). e Visualization of the clonal frequency of barcodes in primary tumor by bar length (left side of dotted line) and ordered by frequency along the y-axis (represented on square-root scale to highlight dominant clones), with the corresponding number of cells of the same clone estimated in lungs (right sides of dotted line). Blue bars indicate clones that were under-represented (<10-fold compared to frequency in primary tumor), and red bars indicate over-represented in lung (>10-fold compared to frequency in primary tumor). f Ratio of frequency in primary tumor compared to lung for all barcodes from all mice detected in both organs, with a cut-off for clones 10-fold over-represented (red) and 10-fold under-represented (blue), with indicated proportions of red and blue barcoded clones when tumor was present and large (T2), and at late metastatic disease after tumor resection (T3)
Fig. 4 Characteristics of metastatic ‘seeder’ clones after tumor resection. Clonal relationships between resected primary tumor at T1 vs. metastatic lung disease at T3 in a PDX-110 and b PDX-322. Each color represents the clones from one mouse of a total of seven mice for PDX-110 from two independent experiments, n = 9 mice for PDX-322 from three independent experiments. Inset gives adjusted R2 and p-values using the F-test for linear regression on log-transformed frequencies of barcodes detected in both tissues. c Correlation of clonal relationship between indicated organs based on a and b between distal tissues at T3 compared to resected primary tumor at T1. Data represent 20 mice for PDX-110 from two independent experiments and 23 mice for PDX-322 from four independent experiments (mean ± SEM). d Change in the proportion of barcodes detected in lung prior to (T1) and after (T3) tumor resection in the indicated PDX (mean ± SEM). e Visualization of the clonal frequency of barcodes in primary tumor by bar length (left side of dotted line) and ordered by frequency along the y-axis (represented on square-root scale to highlight dominant clones), with the corresponding number of cells of the same clone estimated in lungs (right sides of dotted line). Blue bars indicate clones that were under-represented (<10-fold compared to frequency in primary tumor), and red bars indicate over-represented in lung (>10-fold compared to frequency in primary tumor). f Ratio of frequency in primary tumor compared to lung for all barcodes from all mice detected in both organs, with a cut-off for clones 10-fold over-represented (red) and 10-fold under-represented (blue), with indicated proportions of red and blue barcoded clones when tumor was present and large (T2), and at late metastatic disease after tumor resection (T3)CC BY · PubMed Central
Fig. 5 Properties of multi-organ metastases. a Individual mouse examples of clonal relationships between indicated organs from PDX-110 and -322. Each barcode is indicated by a color for individual mice. The color codes are not conserved between different mice. b Number of clones that are found in none (i.e. in tumor only) or one or more metastatic sites for 4 (PDX-110) or 3 (PDX-322) individual mice (each mouse represented by a line)
Fig. 5 Properties of multi-organ metastases. a Individual mouse examples of clonal relationships between indicated organs from PDX-110 and -322. Each barcode is indicated by a color for individual mice. The color codes are not conserved between different mice. b Number of clones that are found in none (i.e. in tumor only) or one or more metastatic sites for 4 (PDX-110) or 3 (PDX-322) individual mice (each mouse represented by a line)CC BY · PubMed Central
Fig. 6 The effect of cisplatin on clonal diversity. a Average volume of tumors from PDX-110 treated with vehicle, or cisplatin (6 mg/kg, treatment time indicated by a triangle at the bottom for either 1 or 2 cycles). Tumor volume from 12 mice per group (mean ± SEM). b Bubble plot of clonal relationships between indicated tissues of all mice, with indicated average barcode number per mouse (mean ± SEM) in tumor, CTC, and lung. Colors indicate different mice. c Percentage of barcoded clones in vehicle or cisplatin treatment group at tumor relapse relative to vehicle-treated controls in indicated tissues (shown is mean ± SEM, ns: t-test, not significant, *p < 0.05). d Shannon diversity and e Simpson index of barcode distribution in different organs in the treated and untreated group. Scatter plots showing the correlation between the frequencies of barcoded clones in primary tumor versus f lung (n = 10 mice) and g blood and lung (n = 9 mice). Inset indicates adjusted R2 and p-values using the F-test for linear regression on log-transformed frequencies of barcodes detected in both tissues
Fig. 6 The effect of cisplatin on clonal diversity. a Average volume of tumors from PDX-110 treated with vehicle, or cisplatin (6 mg/kg, treatment time indicated by a triangle at the bottom for either 1 or 2 cycles). Tumor volume from 12 mice per group (mean ± SEM). b Bubble plot of clonal relationships between indicated tissues of all mice, with indicated average barcode number per mouse (mean ± SEM) in tumor, CTC, and lung. Colors indicate different mice. c Percentage of barcoded clones in vehicle or cisplatin treatment group at tumor relapse relative to vehicle-treated controls in indicated tissues (shown is mean ± SEM, ns: t-test, not significant, *p < 0.05). d Shannon diversity and e Simpson index of barcode distribution in different organs in the treated and untreated group. Scatter plots showing the correlation between the frequencies of barcoded clones in primary tumor versus f lung (n = 10 mice) and g blood and lung (n = 9 mice). Inset indicates adjusted R2 and p-values using the F-test for linear regression on log-transformed frequencies of barcodes detected in both tissuesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 145

Metadata

Authors
Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y., Asselin-Labat, M. L., Schumacher, T. N., Cameron, D., Smyth, G. K., Papenfuss, A. T., Lindeman, G. J., Visvader, J. E., & Naik, S. H.
Affiliations
  • The University of Melbourne (AU)
  • The Netherlands Cancer Institute (NL)
  • Walter and Eliza Hall Institute of Medical Research (AU)
  • The Royal Melbourne Hospital (AU)
Corresponding author
  • Visvader, J. E.
  • Naik, S. H.
Venue
Nature Communications
Published
2019-02-15
Volume
10
Issue
1
Pages
766-766
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2912649747
Cited by
145
References
56
Citations by year
2026: 7 · 2025: 18 · 2024: 22 · 2023: 21 · 2022: 23 · 2021: 28 · 2020: 16 · 2019: 10
FWCI
6.07
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Australian Cancer Research Foundation
  • National Breast Cancer Foundation
  • Medical Research Council (1016701)
  • National Health and Medical Research Council (1116955, 1102742, 1054618, 1086727, 1058892, 1040978, 1016701, 1101378, 1124812, 1037230, 1078730, 1062820)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
triple-negative breast cancer, patient-derived xenografts, cellular barcoding, clonal evolution, metastasis, disseminated tumor cells, tumor seeding, tumor resection, cisplatin, BRCA1 mutation, drug resistance, clonal diversity
MeSH terms
Animals, Cisplatin, Clone Cells, Disease Models, Animal, Female, Humans, Mutation, Neoplasm Recurrence, Local, Gene Expression Regulation, Neoplastic, BRCA1 Protein, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. https://app.cochat.ai/papers/10.1038/s41467-019-08595-2
The paper
Merino, D., Weber, T. S., Serrano, A., Vaillant, F., Liu, K., Pal, B., Di Stefano, L., Schreuder, J., Lin, D., Chen, Y., Asselin-Labat, M. L., Schumacher, T. N., Cameron, D., Smyth, G. K., Papenfuss, A. T., Lindeman, G. J., Visvader, J. E., & Naik, S. H. (2019). Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nature Communications. https://doi.org/10.1038/s41467-019-08595-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.